UPDATE
: Monday, September 7, 2020
Home
Login
Mobile Version
All
Hospital
Pharma
Bio
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Special Series in Celebration of KBR’s 3rd Anniversary
Special Series in Celebration of KBR’s 4th Anniversary
ASCO 2020 Highlights
Opinion
Reporter’s Notebook
Search
트위터
페이스북
RSS
상단여백
제목보기
제목보기
제목+내용
SK Chemicals, Lilly Korea to market osteoporosis treatment
SK Chemicals said Thursday that it would co-market Forsteo, an osteoporosis...
by Lee Han-soo
|
2018-04-19 13:51
라인
B. Braun Korea names Stephan Soyka as new general manager
Stephan Soyka German medical device firm B. Braun said Thursday that it n...
by Marian Chu
|
2018-04-19 13:34
라인
Hanmi unveils 3 drug candidates at US cancer conference
Visitors view Hanmi's research results on anti-cancer drug candidates at th...
by Lee Han-soo
|
2018-04-18 16:49
라인
AstraZeneca up, Novartis down in Q1 outpatient prescriptions
AstraZeneca Korea’s outpatient prescription drug sales expanded by 7 billio...
by Nam Doo-hyun
|
2018-04-18 14:58
라인
Roche Korea gets expanded approval for breast cancer drug
Roche Korea said that its breast cancer therapy Perjeta got the Ministry of...
by Marian Chu
|
2018-04-18 13:13
라인
Exhibition showcases latest pharma products, trends
An international pharmaceutical exhibition opened at the Korea Internationa...
by Lee Hye-seon
|
2018-04-17 16:14
라인
Genexine unveils trial results for immunotherapeutic agent
Genexine and NeoImmuneTech said Tuesday that they have presented animal tri...
by Lee Han-soo
|
2018-04-17 15:13
라인
How are Korean drugmakers performing in China?
The pharmaceutical industry is paying attention to how Korean drugmakers ar...
by So Jae-hyeon
|
2018-04-17 15:12
라인
Handok to sell Astellas’ diabetes therapy
Handok said Monday that it signed a sales contract with Astellas Korea to s...
by Marian Chu
|
2018-04-17 13:52
라인
GemVax & KAEL gets positive P2 data on GV1001 for prostate hyperplasia
GemVax & KAEL said that it proved clinical efficacy of GV1001 on benign pro...
by Marian Chu
|
2018-04-16 16:50
라인
Humedix eyes global entry with skin-regenerating injection
Humedix, a Huons Global subsidiary, said it got approvals for both Revitalr...
by Marian Chu
|
2018-04-16 14:47
라인
Will anti-smoking drug Champix still be champion?
Korean drugmakers are expected to roll out generic copies of Pfizer’s smoki...
by So Jae-hyeon
|
2018-04-16 14:46
라인
Janssen Korea launches new psoriasis treatment
Janssen Korea said it has launched a follow-up drug of psoriasis treatment ...
by Lee Hye-seon
|
2018-04-16 11:48
라인
GE Healthcare Korea launches ₩2.5-bil. program to foster biotech
GE Healthcare Life Sciences Korea said Monday that it would provide 2.5 bil...
by Marian Chu
|
2018-04-16 11:45
라인
Roche Korea’s Alecensa gets approval as 1st line lung cancer therapy
Roche’s lung cancer therapy got the Ministry of Food and Drug Safety’s appr...
by Marian Chu
|
2018-04-13 16:46
라인
SillaJen reveals clinical results on Pexa-Vec in UK
SillaJen said it unveiled clinical results of REN022, a phase-2 study on Pe...
by So Jae-hyeon
|
2018-04-13 16:38
라인
Hanmi gives up on lung cancer drug Olita
Hanmi Pharmaceutical is expected to discontinue developing lung cancer trea...
by Lee Hye-seon
|
2018-04-13 11:00
라인
LG Chem works on 3-in-1 combo for hypertension
LG Chem said it has won approval from the Ministry of Food and Drug Safety ...
by Lee Hye-seon
|
2018-04-12 16:32
라인
Obesity drug Saxenda’s sheds ‘1-year effect’ stigma
The government has changed its approval for the efficacy and safety of Saxe...
by Nam Doo-hyun
|
2018-04-11 14:11
라인
YD Life Science preps diabetes complication therapy for global launch
YD Life Science said it got the U.S. Food and Drug Administration’s go-ahea...
by Marian Chu
|
2018-04-10 17:36
-
이전
81
82
83
84
85
86
87
88
89
90
다음
-
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
여백
Most viewed
1
‘Cyramza helped improve gastric cancer treatment in Korea’
2
‘Reduced-dose prasugrel effective for ACS patients undergoing PCI’
3
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
4
SNUBH develops AI model predicting patients at risk of cerebral aneurysm
5
Novavax releases encouraging phase-1 results on Covid-19 vaccine candidate
6
LG Chem, SK Bioscience end sales partnership with Daewoong
7
UBcare wins patent for tech to monitor suspected infectious diseases
8
176 civic groups furious over government-doctors deal
9
Recovered Covid-19 patients suffer from aftereffects – for long
10
Regulator OKs JW Pharma's rheumarthritis drug for treating giant cell arteries
여백
Opinion
[Column] Correct diagnosis leads to proper treatment
[Column] How ongoing doctors’ strike is different from 20 years ago
A Korean-American Doctor asks: Is Korea truly in 2020?
여백
Back to Top